Inherent Biosciences Raises Seed Round, adds Board Members and Clinical Advisors
By: Andy Olson
February 17, 2021

Salt Lake City, Utah (Newswire.com) — Inherent Biosciences today announced its initial capital raise led by Morning Star Foundation with additional participation from MedMountain Ventures, Kickstart Funds, Park City Angels, Rhythm VC and several angel investors. With the initial funding, Inherent will launch a male infertility diagnostic to guide infertility treatment.
Inherent also added members to its Board of Directors and Clinical Advisors:
-
Lewis Rumpler – Former CEO of Epigenesys, Executive Chairman
-
Saumitra Thakur, MD – MedMountain Ventures, Director
-
David Shriner – Morning Star Foundation, Director
-
Tia Newcomer – Independent Director
-
Tom Simpson – Kick Start Funds, Board Observer
-
Doug Carrell, PhD, HCLD – Andrology Advisor
-
Paul Turek, MD – Clinical Advisor
-
Larry Lipshultz, MD – Clinical Advisor